Fig. 9From: Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysisOverall survival analysis of MCM3 and GINS2 expression with prognosis of ovarian cancer patients. The patients with ovarian cancer were divided into two groups (high vs. low), according to the median expression level of MCM3 and GINS2Back to article page